New findings show programmable biomaterials can be delivered using needle injection to induce an immune response and fight deadly diseases
One of the reasons cancer is so deadly is that it can evade attack from the body’s immune system, which allows tumors to flourish and spread. Scientists can try to induce the immune system, known as immunotherapy, to go into attack mode to fight cancer and to build long lasting immune resistance to cancer cells. Now, researchers at the Wyss Institute for Biologically Inspired Engineering at Harvard University and Harvard’s School of Engineering and Applied Sciences (SEAS) show a non–surgical injection of programmable biomaterial that spontaneously assembles in vivo into a 3D structure could fight and even help prevent cancer and also infectious disease such as HIV. Their findings are reported in Nature Biotechnology.
“We can create 3D structures using minimally–invasive delivery to enrich and activate a host’s immune cells to target and attack harmful cells in vivo,” said the study’s senior author David Mooney, Ph.D., who is a Wyss Institute Core Faculty member and the Robert P. Pinkas Professor of Bioengineering at Harvard SEAS.
Tiny biodegradable rod–like structures made from silica, known as mesoporous silica rods (MSRs), can be loaded with biological and chemical drug components and then delivered by needle just underneath the skin. The rods spontaneously assemble at the vaccination site to form a three–dimensional scaffold, like pouring a box of matchsticks into a pile on a table. The porous spaces in the stack of MSRs are large enough to recruit and fill up with dendritic cells, which are “surveillance” cells that monitor the body and trigger an immune response when a harmful presence is detected.
“Nano–sized mesoporous silica particles have already been established as useful for manipulating individual cells from the inside, but this is the first time that larger particles, in the micron–sized range, are used to create a 3D in vivo scaffold that can recruit and attract tens of millions of immune cells,” said co-lead author Jaeyun Kim, Ph.D., an Assistant Professor of Chemical Engineering at Sungkyunkwan University and a former Wyss Institute Postdoctoral Fellow.
Synthesized in the lab, the MSRs are built with small holes, known as nanopores, inside. The nanopores can be filled with specific cytokines, oligonucleotides, large protein antigens, or any variety of drugs of interest to allow a vast number of possible combinations to treat a range of infections.
“Although right now we are focusing on developing a cancer vaccine, in the future we could be able to manipulate which type of dendritic cells or other types of immune cells are recruited to the 3D scaffold by using different kinds of cytokines released from the MSRs,” said co-lead author Aileen Li, a graduate student pursuing her Ph.D. in bioengineering at Harvard SEAS. “By tuning the surface properties and pore size of the MSRs, and therefore controlling the introduction and release of various proteins and drugs, we can manipulate the immune system to treat multiple diseases.”
The Latest on: Injectable 3D vaccines
via Google News
The Latest on: Injectable 3D vaccines
- Novel Chimeric Multiepitope Vaccine for Streptococcosis Disease in Nile Tilapia (Oreochromis niloticus Linn.)on January 17, 2020 at 2:14 am
The epitope arrangements in 45F2 and 42E2 were represented in a 3D structure of chimeric proteins ... 7:3 ratio prior to intraperitoneal injection with 200 µg of protein per fish. For the chimeric ...
- Research in China Yields New DLP 3D Printed Microneedleson January 12, 2020 at 10:40 pm
The use of microneedles continues to increase due to benefits they offer patients, along with uses such as vaccinations ... needle using in biological injection and drug extraction. Due to the ...
- Intravenous administration boosts protective power of TB vaccineon January 2, 2020 at 2:59 am
compared to the standard injection directly into the skin, which offers minimal protection. The effects are amazing. When we compared the lungs of animals given the vaccine intravenously versus ...
- Intravenous TB vaccination may succeed where injections failon January 1, 2020 at 4:00 pm
a stronger-dose injection, an inhaled vaccine mist, a mist plus an injection, and finally a shot of the stronger dose straight into a vein – intravenously, in other words. Six months later ...
- Biggest medical breakthroughs of the last decadeon December 22, 2019 at 3:01 am
How CRISPR technology works How AIDS drugs could end the HIV pandemic Developing a vaccine for the Ebola ... They used to have to take injections of insulin throughout the day to regulate their ...
- More current polio cases have been caused by vaccines than the wild virus: WHO reporton November 26, 2019 at 5:04 am
Western countries are known to use a more expensive injectable vaccine, which contain an inactivated virus that is incapable of actually causing polio. While the oral vaccine did help some ...
- WHO to use key data from malaria vaccine pilots for policy makingon September 15, 2019 at 7:04 pm
Known side effects include pain and swelling at the injection site, and fever. These side effects are similar to reactions observed with other vaccines given to children.
- Fillable microparticles designed to achieve single-injection vaccineson October 29, 2017 at 5:00 pm
The study was born out of a partnership with the Bill and Melinda Gates Foundation, which was interested in developing single-injection vaccines for children in developing ... The team initially ...
- New 3D Printing Method Combines Multiple Vaccines into One Shoton September 17, 2017 at 9:34 am
Experts have talked about the possibility of making life easier for people who take multiple medications by combining them all in one 3D printed ... injection to deliver multiple vaccine doses ...
- Super injection may deliver childhood vaccines in one jabon September 14, 2017 at 9:03 pm
MIT scientists have developed a new technology that may help develop a 'super injection' which can deliver all childhood vaccines through a single jab. MIT scientists have developed a new ...
via Bing News